NPS-1034
CAS: 1221713-92-3
Ref. 3D-WYB71392
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
NPS-1034 is a compound that inhibits the transcription-polymerase chain reaction (PCR) activity of tyrosine kinases. The active form of NPS-1034 binds to the ATP site on the polymerase and blocks DNA elongation, which leads to cell death. This drug has been shown to be effective in treating cervical cancer cells in vitro, as well as being synergistic with platinum-based chemotherapy agents. NPS-1034 has pharmacokinetic properties that allow it to cross the blood brain barrier and enter the central nervous system, making it an attractive candidate for treating brain tumours or neurodegenerative diseases. In addition, this drug also has been shown to inhibit epidermal growth factor receptor (EGFR) activation in human protein and cell culture studies.
Chemical properties
Technical inquiry about: 3D-WYB71392 NPS-1034
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
